肺癌CT筛查:三种基线筛查方案比较
比较I-ELCAP、ACR-LungRADS两种情景及欧洲联盟共三种基线筛查方案对立即和延迟(3或6个月)检查的建议效率,以效率比(推荐检查人数除以确诊肺癌人数)衡量。I-ELCAP在总体、立即、延迟检查及潜在活检的效率比均最低。方案阈值的小差异可导致大量不必要的诊断性检查。
要点
- I-ELCAP方案在总体、立即、延迟检查及潜在活检的效率比均最低。
- ACR-LungRADS两种情景总体效率比均为18.3,欧洲联盟为31.9。
- 潜在活检效率比I-ELCAP为2.2,ACR-LungRADS情景1为8.1、情景2为3.2,欧洲联盟为4.4。
核心结论
- I-ELCAP方案在总体、立即和延迟检查及潜在活检的效率比均最低。
研究设计与样本
- 比较三种基线筛查方案(I-ELCAP、ACR-LungRADS两种情景、欧洲联盟)对立即和延迟(3或6个月)检查的建议效率比。
诊断标准与关键数值
- 立即检查效率比:I-ELCAP 2.9,ACR-LungRADS情景1 8.6,ACR-LungRADS情景2 3.9,欧洲联盟5.6。
- 延迟检查效率比:I-ELCAP 36.1,ACR-LungRADS情景1 160.3,ACR-LungRADS情景2 57.8,欧洲联盟111.9。
- 总体效率比:I-ELCAP 13.9,ACR-LungRADS情景1 18.3,ACR-LungRADS情景2 18.3,欧洲联盟31.9。
- 潜在活检效率比:I-ELCAP 2.2,ACR-LungRADS情景1 8.1,ACR-LungRADS情景2 3.2,欧洲联盟4.4。
临床应用与阅片要点
- I-ELCAP方案在总体、立即、延迟检查及潜在活检中效率比均最低。
- 方案阈值的小差异可导致许多不必要的诊断性检查。
- 作者指出基线筛查「阳性结果」定义及进一步检查建议需持续重新评估和更新。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSE: Clinical management decisions arising from the baseline round for lung cancer screening are the most challenging, as findings have accumulated over a lifetime and may be of no clinical concern. To minimize unnecessary harms and costs of workup prior to the first, annual repeat screening, workup should be limited to participants with the highest suspicion of lung cancer while still aiming to identify small, early lung cancers.
METHODS: We compared recommendations for immediate, delayed (by 3 or 6 months) workup to assess growth at a malignant rate, and the resulting overall and potential biopsies of three baseline screening protocols: I-ELCAP, the two scenarios of ACR-LungRADS, and the European Consortium. For each protocol, the efficiency ratio (ER) of each recommendation was calculated by dividing the number of participants recommended for that workup by the number of resulting lung cancer diagnoses. The ER for potential biopsies was calculated, assuming that biopsies were performed on all participants recommended for immediate workup as well as those diagnosed with lung cancer after delayed workup.
RESULTS: For I-ELCAP, ACR-LungRADS Scenario 1, ACR-LungRADS Scenario 2, and the European consortium, the overall ER was 13.9, 18.3, 18.3, and 31.9, respectively, and for potential biopsies, it was 2.2, 8.1, 3.2, and 4.4, respectively. ER for immediate workup was 2.9, 8.6, 3.9, and 5.6, respectively, and for delayed workup was 36.1, 160.3, 57.8, and 111.9, respectively.
CONCLUSIONS: I-ELCAP recommendations had the lowest ER values for overall, immediate, and delayed workup, and for potential biopsies.
KEY POINTS: • Small differences in protocol thresholds can lead to many unnecessary diagnostic workups. • I-ELCAP recommendations were the most efficient for immediate and overall workup, and potential biopsies. • Definition of a "positive result" and recommendations for further workup in the baseline round needs to be continually reevaluated and updated.
引用
- Henschke CI, Yip R, Ma T, et al. CT screening for lung cancer: comparison of three baseline screening protocols. Eur Radiol. 2018. PMID: 30511179. doi:10.1007/s00330-018-5857-5
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。